Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 40 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 10391098

    Antisense antibacterial compounds and methods

    The Board of Regents of the University of Texas System · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  2. US 10391183

    Infectivity-enhanced conditionally-replicative adenovirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  3. US 10392376

    Heterocyclic inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  4. US 10391126

    CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

    The Board of Regents of the University of Texas System · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  5. US 10383943

    Compositions and related methods for the treatment of cancer

    SOUTH DAKOTA BOARD OF REGENTS · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted

  6. US 10383940

    Copper-cysteamine and methods of use

    The Board of Regents of the University of Texas System · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted

  7. US 10385080

    STAT6 inhibitors

    The Board of Regents of the University of Texas System · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted

  8. US 10379109

    Systems and methods for high-resolution imaging

    The Board of Regents of the University of Texas System · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

  9. US 10377796

    Inhibition of pulmonary fibrosis with nutlin-3a and peptides

    The Board of Regents of the University of Texas System · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

  10. US 10376574

    Compositions and methods for vaccination against influenza A virus

    SOUTH DAKOTA BOARD OF REGENTS · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

  11. US 10378058

    Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer

    The Board of Regents of the University of Texas System · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

  12. US 10369103

    Neuroprotective liposome compositions and methods for treatment of stroke

    The Board of Regents of the University of Texas System · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  13. US 10370419

    Tuberculosis vaccine compositions and related methods

    THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXTAS SYSTEM · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  14. US 10370679

    Modified immunization vectors

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  15. US 10370360

    Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  16. US 10363319

    Glycoconjugates and methods for their use

    The Board of Regents of the University of Texas System · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  17. US 10364227

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  18. US 10363261

    Enolase inhibitors and methods of treatment therewith

    The Board of Regents of the University of Texas System · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  19. US 10363282

    Analogs of C5a and methods of using same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  20. US 10363311

    Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

    The Board of Regents of the University of Texas System · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  21. US 10363245

    Methods for treating CNS lesions

    The Board of Regents of the University of Texas System · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  22. US 10363248

    Salts of heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  23. US 10358439

    DNA binding agents with a minor groove binding tail

    The Board of Regents of the University of Texas System · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  24. US 10357448

    Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi

    The Board of Regents of the University of Texas System · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.